论文部分内容阅读
目的 探讨晚期卵巢上皮癌行腹膜后淋巴结清除的价值。方法 ８５ 例晚期卵巢上皮癌患者根据清除腹膜后淋巴结与否分成Ａ、Ｂ两组，Ａ 组４２ 例，Ｂ组４３ 例；再将两组患者根据肿瘤细胞减灭术（ 减灭术） 后残瘤灶直径≥２ｃｍ 和＜ ２ｃｍ 分成两组进行比较。结果 两组５ 年存活率分别为３８－１ ％ 和２７－９ ％ （ Ｐ ＜ ０－０５） 。Ａ 组残瘤灶直径＜ ２ｃｍ 与Ｂ组残瘤灶直径＜ ２ｃｍ 存活率分别为５３－８ ％ 和３４－６ ％ （ Ｐ＜ ０－０５） ；Ａ、Ｂ两组残瘤灶直径≥２ｃｍ 存活率分别为１２－５％ 和１７－７％ （ Ｐ＞ ０－０５） 。结论 晚期卵巢上皮性癌在减灭术理想前提下行腹膜后淋巴结清除术可以提高存活率。反之，若减灭术不理想时，行腹膜后淋巴结清除术不能提高存活率。
Objective To investigate the value of retroperitoneal lymph node dissection in advanced epithelial ovarian cancer. Methods Eighty-five patients with advanced epithelial ovarian cancer who were divided into A and B groups according to whether they had retroperitoneal lymph node dissection were divided into two groups: group A (42 cases) and group B (43 cases). According to the tumor cytoreductive surgery Tumor diameter ≥ 2cm and <2cm were divided into two groups for comparison. Results The 5-year survival rates of the two groups were 38-1% and 27-9%, respectively (P <0-05). A group of residual tumor diameter <2cm and B group residual tumor diameter <2cm survival rates were 53-8% and 34-6% (P <0-05); A, B two groups of residual tumor diameter ≥ 2cm survival Rates were 12-5% and 17-7%, respectively (P> 0-05). Conclusion Advanced retroperitoneal lymphadenectomy can improve the survival rate of patients with advanced epithelial ovarian cancer under the ideal condition of ablation. Conversely, if ablation is not ideal, retroperitoneal lymph node dissection can not improve survival.